講演情報
[FPoIQwB5-06]Quality of Life and Mental Health Status Among Patients with Chronic Kidney Disease in Public Tertiary Hospitals in Bangladesh
*Shuvo Md Jobael1, Dr. ABM Alauddin Chowdhury2, Md. Biplob Hossain3 (1. The Kyoto College of Graduate Studies for Informatics (Japan), 2. Daffodil International University (Bangladesh), 3. German University Bangladesh (Bangladesh))
キーワード：
Chronic kidney disease、quality of life、anxiety、depression、mental health、Bangladesh
Background: Chronic kidney disease (CKD) affects approximately 800 million people globally and represents a major public health challenge. In Bangladesh, the estimated prevalence is 22.48%, considerably higher than the global average, and CKD is among the leading causes of mortality. While clinical management primarily addresses physical complications, but psychological well-being and quality of life (QoL) remain underexplored, particularly in resource-constrained public hospitals. This study assessed QoL and mental health status among CKD patients in Bangladesh and identified associated factors.
Methods: A cross-sectional study was conducted from January 2025 to December 2025 among 309 CKD patients, recruited through purposive sampling at Bangladesh Medical University a public tertiary hospital. Data were collected through face-to-face interviews using a structured Bengali questionnaire. QoL was measured using the validated Kidney Disease Quality of Life (KDQOL) instrument. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS). Statistical analyses were performed using Stata. Associations between variables and QoL were examined using regression analysis, with p<0.05 considered statistically significant.
Results: The mean age of participants was 39.96 years; 52.75% were male and 76.0% were married. Clinically significant anxiety was present in 97.41% of participants, of whom 55.66% had a prior history of depressive symptoms. Overall, 63.75% reported poor quality of life. Poor QoL was significantly associated with age above 50 years (OR 3.14; 95% CI 1.37-7.21; p=0.007), male gender (OR 2.36; 95% CI 1.47–3.79; p<0.001), smoking (OR 1.63; 95% CI 1.00-2.64; p=0.046), alcohol consumption (OR 4.36; 95% CI 1.78-10.66; p=0.001), and cancer (OR 5.00; 95% CI 1.72-14.60; p=0.003).
Conclusions: CKD patients in Bangladesh experience a high burden of anxiety and poor QoL. Key factors include older age, male gender, unhealthy behaviors, and comorbidities. Integrating psychosocial care and lifestyle interventions into CKD management is essential to improve outcomes.
Methods: A cross-sectional study was conducted from January 2025 to December 2025 among 309 CKD patients, recruited through purposive sampling at Bangladesh Medical University a public tertiary hospital. Data were collected through face-to-face interviews using a structured Bengali questionnaire. QoL was measured using the validated Kidney Disease Quality of Life (KDQOL) instrument. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS). Statistical analyses were performed using Stata. Associations between variables and QoL were examined using regression analysis, with p<0.05 considered statistically significant.
Results: The mean age of participants was 39.96 years; 52.75% were male and 76.0% were married. Clinically significant anxiety was present in 97.41% of participants, of whom 55.66% had a prior history of depressive symptoms. Overall, 63.75% reported poor quality of life. Poor QoL was significantly associated with age above 50 years (OR 3.14; 95% CI 1.37-7.21; p=0.007), male gender (OR 2.36; 95% CI 1.47–3.79; p<0.001), smoking (OR 1.63; 95% CI 1.00-2.64; p=0.046), alcohol consumption (OR 4.36; 95% CI 1.78-10.66; p=0.001), and cancer (OR 5.00; 95% CI 1.72-14.60; p=0.003).
Conclusions: CKD patients in Bangladesh experience a high burden of anxiety and poor QoL. Key factors include older age, male gender, unhealthy behaviors, and comorbidities. Integrating psychosocial care and lifestyle interventions into CKD management is essential to improve outcomes.
コメント
コメントの閲覧・投稿にはログインが必要です。ログイン